As of 2026-03-14, the Relative Valuation of Albireo Pharma Inc (ALBO) is (134.97) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -405.7%.
The range of the Relative Valuation is (119.73) - (141.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.8x | 21.1x |
| Forward P/E multiples | 18.1x - 22.4x | 21.6x |
| Fair Price | (119.73) - (141.86) | (134.97) |
| Upside | -371.2% - -421.3% | -405.7% |
| Date | P/E |